Indicators
Coagulation Factor XII
Coagulation factor XII (615 aa, ~68 kDa) is encoded by the human F12 gene. This protein is involved in blood coagulation and fibrinolysis.
Loading
Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Indicators
Coagulation factor XII (615 aa, ~68 kDa) is encoded by the human F12 gene. This protein is involved in blood coagulation and fibrinolysis.
Company
Biomarker is a Swedish original manufacturer of advanced reagents, calibrators and controls for coagulation and clinical chemistry analyzers and offers products used for a wide
Article
Research record from J Thromb Haemost, 2026-03-04. PMID 41791653.
Indicators
Antithrombin-III (464 aa, ~53 kDa) is encoded by the human SERPINC1 gene. This protein is involved in the negative regulation of serine proteinase activity during blood coagulation.
Indicators
Coagulation factor IX (461 aa, ~52 kDa) is encoded by the human F9 gene. This protein plays a role in the intrinsic pathway of blood coagulation through the mediation of proteolysis that converts factor X into an active protease.
Tests
Coagulation factors are proteins in your blood. They help form blood clots to stop bleeding when you have an injury. These proteins are also called clotting factors. You have several different types of clotting factors that are all important for making blood clots.
Indicators
Coagulation factor V (2224 aa, ~252 kDa) is encoded by the human F5 gene. This protein plays a role in the coagulation cascade.
Indicators
Coagulation factor VII (466 aa, ~52 kDa) is encoded by the human F7 gene. This protein is involved in both binding to tissue factor and the initiation of blood coagulation.
Indicators
Coagulation factor X (488 aa, ~55 kDa) is encoded by the human F10 gene. This protein is involved in proteolysis and blood coagulation.
Indicators
Coagulation factor XI (625 aa, ~70 kDa) is encoded by the human F11 gene. This protein is involved in the proteolytic activation of coagulation factor IX.
Tests
A measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation.
Article
Research record from Infect Drug Resist, 2026-09-05. PMID 42719848.